News

Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
Even when equities are volatile, investors can find great stocks to buy ... dip. Merck's woes predate the current economy. The company's shares have been falling because its biggest drug, cancer ...
ANN ARBOR, Mich. - Esperion Therapeutics (NASDAQ:ESPR) has announced a strategic partnership with HLS Therapeutics (TSX:HLS), granting the latter exclusive rights to commercialize two ...
Merck buys rights to heart disease drug in latest China deal Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion ...
These three Vanguard ETFs look like top buys right now. Passive investing through exchange-traded funds (ETFs) has become a cornerstone strategy for building long-term wealth, especially for ...
Getting a shingles vaccine may help with more than the viral infection that causes painful rashes — new research shows it can also lower the risk of heart disease. In a study, published Monday ...
Stuart Ford’s AGC is selling worldwide rights and cameras are rolling in Paris and Marseille. Barnaby Thompson directs. Deadline first told you about the project at Series Mania in March ...
NHS trusts should provide access to a range of drug-eluting stents, so that a clinically appropriate stent is available for everyone with coronary artery disease. If more than one drug-eluting stent ...
They agreed to purchase a pair of rights-of-way on the Rogers-Craig county line, easements the county needs so the Oklahoma Department of Transportation can construct a bridge at a low-water ...
One stock to keep an eye on is Merck KGaA (MKKGY). MKKGY is currently holding a Zacks Rank of #2 (Buy) and a Value grade ... the stock is likely undervalued right now. When factoring in the ...
The study estimated that DEHP exposure contributed to 356,238 global deaths in 2018, accounting for nearly 13.5% of heart disease deaths among people aged 55-64. This finding aligns with previous ...